Target intelligence / Profile preview

Apoptosis inhibitor 5 pseudogene 2 (API5P2)

Target: API5P2
Molecular classification: Other (Pseudogene)

Overview

Apoptosis inhibitor 5 pseudogene 2 (API5P2) is a human pseudogene related to the coding gene apoptosis inhibitor 5 (API5). It does not code for a functional protein and is not considered a therapeutic target. There is no evidence that API5P2 has biological function, pathology, or relevance as a biomarker or drug target. Its only significance is in genomic annotation as a processed or unprocessed pseudogene, with no role in established disease mechanisms or therapy[1][4].

Other names: API5 pseudogene 2Apoptosis inhibitor 5 pseudogene 2API5P2

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on Apoptosis inhibitor 5 pseudogene 2 (API5P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis inhibitor 5 pseudogene 2 (API5P2).

Explore the full profile